Abstract
The extracellular matrix (ECM) is a guiding force that regulates various developmental stages of the breast. In addition to providing structural support for the cells, it mediates epithelial-stromal communication and provides cues for cell survival, proliferation, and differentiation. Perturbations in ECM architecture profoundly influence breast tumor progression and metastasis. Understanding how a dysregulated ECM can facilitate malignant transformation is crucial to designing treatments to effectively target the tumor microenvironment. Here, we address the contribution of ECM mechanics to breast cancer progression, metastasis, and treatment resistance and discuss potential therapeutic strategies targeting the ECM.
Similar content being viewed by others
References
Wiseman, B. S., & Werb, Z. (2002). Stromal effects on mammary gland development and breast cancer. Science (New York, N.Y.), 296(5570), 1046–1049. doi:10.1126/science.1067431.
Robinson, G. W., Karpf, a. B., & Kratochwil, K. (1999). Regulation of mammary gland development by tissue interaction. Journal of Mammary Gland Biology and Neoplasia, 4(1), 9–19. doi:10.1023/A:1018748418447.
Wicha, M. S., Liotta, L. A., Vonderhaar, B. K., & Kidwell, W. R. (1980). Effects of inhibition of basement membrane collagen deposition on rat mammary gland development. Developmental Biology, 80(2), 253–266. doi:10.1016/0012-1606(80)90402-9.
Silberstein, G. B., & Daniel, C. W. (1982). Glycosaminoglycans in the basal lamina and extracellular matrix of the developing mouse mammary duct. Developmental Biology, 90(1), 215–222. doi:10.1016/0012-1606(82)90228-7.
Fata, J. E., Werb, Z., & Bissell, M. J. (2004). Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast cancer research: BCR, 6(1), 1–11. doi:10.1186/bcr634.
Paszek, M. J., & Weaver, V. M. (2004). The tension mounts: mechanics meets morphogenesis and malignancy. Journal of Mammary Gland Biology and Neoplasia. doi:10.1007/s10911-004-1404-x.
Schedin, P., & Keely, P. J. (2011). Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression. Cold Spring Harbor Perspectives in Biology, 3(1), 1–22. doi:10.1101/cshperspect.a003228.
Schedin, P., & Keely, P. J. (2011). and Mechanosignaling in normal development and tumor progression, 1–22. doi:10.1101/cshperspect.a003228.
Schedin, P., Mitrenga, T., McDaniel, S., & Kaeck, M. (2004). Mammary ECM composition and function are altered by reproductive state. Molecular Carcinogenesis, 41(4), 207–220. doi:10.1002/mc.20058.
Hynes, R. O. (2009). The extracellular matrix: not just pretty fibrils. Science (New York, N.Y.), 326(5957), 1216–1219. doi:10.1126/science.1176009.
Pickup, M. W., Mouw, J. K., & Weaver, V. M. (2014). The extracellular matrix modulates the hallmarks of cancer TL - 15. EMBO Reports, 15 VN-r(12). doi:10.15252/embr.201439246.
Sweet, D. T., Chen, Z., Wiley, D. M., Bautch, V. L., & Tzima, E. (2012). The adaptor protein Shc integrates growth factor and ECM signaling during postnatal angiogenesis. Blood, 119(8), 1946–1955. doi:10.1182/blood-2011-10-384560.
Newman, a. C., Nakatsu, M. N., Chou, W., Gershon, P. D., & Hughes, C. C. W. (2011). The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formation. Molecular Biology of the Cell, 22(20), 3791–3800. doi:10.1091/mbc.E11-05-0393.
Myers, K. A., Applegate, K. T., Danuser, G., Fischer, R. S., & Waterman, C. M. (2011). Distinct ECM mechanosensing pathways regulate microtubule dynamics to control endothelial cell branching morphogenesis. Journal of Cell Biology, 192(2), 321–334. doi:10.1083/jcb.201006009.
Sorokin, L. (2010). The impact of the extracellular matrix on inflammation. Nature reviews. Immunology, 10(10), 712–723. doi:10.1038/nri2852.
Lu, P., Weaver, V. M., & Werb, Z. (2012). The extracellular matrix: a dynamic niche in cancer progression. Journal of Cell Biology, 196(4), 395–406. doi:10.1083/jcb.201102147.
Egeblad, M., Rasch, M. G., & Weaver, V. M. (2010). Dynamic interplay between the collagen scaffold and tumor evolution. Current Opinion in Cell Biology. doi:10.1016/j.ceb.2010.08.015.
Provenzano, P. P., Eliceiri, K. W., Campbell, J. M., Inman, D. R., White, J. G., & Keely, P. J. (2006). Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Medicine, 4(1), 38. doi:10.1186/1741-7015-4-38.
Huijbers, I. J., Iravani, M., Popov, S., Robertson, D., Al-Sarraj, S., Jones, C., & Isacke, C. M. (2010). A role for fibrillar collagen deposition and the collagen internalization receptor endo180 in glioma invasion. PloS One, 5(3). doi:10.1371/journal.pone.0009808.
Zhu, G. G., Risteli, L., Makinen, M., Risteli, J., Kauppila, A., & Stenback, F. (1995). Immunohistochemical study of type I collagen and type I pN-collagen in benign and malignant ovarian neoplasms. Cancer, 75(4), 1010–1017. doi:10.1002/1097-0142(19950215)75:4<1010::AID-CNCR2820750417>3.0.CO;2-O.
Kauppila, S., Stenbäck, F., Risteli, J., Jukkola, A., & Risteli, L. (1998). Aberrant type I and type III collagen gene expression in human breast cancer in vivo. The Journal of Pathology, 186(3), 262–268. doi:10.1002/(SICI)1096-9896(1998110)186:3<262::AID-PATH191>3.0.CO;2-3.
Paszek, M. J., Zahir, N., Johnson, K. R., Lakins, J. N., Rozenberg, G. I., Gefen, A., … Weaver, V. M. (2005). Tensional homeostasis and the malignant phenotype. Cancer cell, 8(3), 241–54. doi: 10.1016/j.ccr.2005.08.010
Lu, P., Takai, K., Weaver, V. M., & Werb, Z. (2011). Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harbor Perspectives in Biology, 3(12), 1–24. doi:10.1101/cshperspect.a005058.
Lopez, J. I., Kang, I., You, W.-K., McDonald, D. M., & Weaver, V. M. (2011). In situ force mapping of mammary gland transformation. Integrative biology: quantitative biosciences from nano to macro, 3(9), 910–921. doi:10.1039/c1ib00043h.
Hu, M., Yao, J., Carroll, D. K., Weremowicz, S., Chen, H., Carrasco, D., … Polyak, K. (2008). Regulation of in situ to invasive breast carcinoma transition. Cancer Cell, 13(5), 394–406. doi: 10.1016/j.ccr.2008.03.007
Lerwill, M. F. (2004). Current practical applications of diagnostic immunohistochemistry in breast pathology. The American Journal of Surgical Pathology, 28, 1076–1091. doi:10.1097/01.pas.0000126780.10029.f0.
Ursin, G., Hovanessian-Larsen, L., Parisky, Y. R., Pike, M. C., & Wu, A. H. (2005). Greatly increased occurrence of breast cancers in areas of mammographically dense tissue. Breast Cancer Research, 7(5), R605–R608. doi:10.1186/bcr1260.
Acerbi, I., Cassereau, L., Dean, I., Shi, Q., Au, A., Park, C., … Weaver, V. M. (2015). Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. Integrative biology: quantitative biosciences from nano to macro, 7(10), 1120–34. doi: 10.1039/c5ib00040h
Conklin, M. W., Eickhoff, J. C., Riching, K. M., Pehlke, C. A., Eliceiri, K. W., Provenzano, P. P., … Keely, P. J. (2011). Aligned collagen is a prognostic signature for survival in human breast carcinoma. American Journal of Pathology, 178(3), 1221–1232. doi: 10.1016/j.ajpath.2010.11.076
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Erler, J. T., Fong, S. F. T., … Weaver, V. M. (2010). NIH Public Access, 139(5), 891–906. doi: 10.1016/j.cell.2009.10.027.Matrix
Ding, J., Warren, R., Girling, A., Thompson, D., & Easton, D. (n.d.). Mammographic density, estrogen receptor status and other breast cancer tumor characteristics. The Breast Journal, 16(3), 279–289. doi:10.1111/j.1524-4741.2010.00907.x.
Conroy, S. M., Butler, L. M., Harvey, D., Gold, E. B., Sternfeld, B., Greendale, G. A., & Habel, L. A. (2011). Metabolic syndrome and mammographic density: the Study of Women’s Health Across the Nation. International Journal of Cancer, 129(7), 1699–1707. doi:10.1002/ijc.25790.
Yaghjyan, L., Colditz, G. A., Collins, L. C., Schnitt, S. J., Rosner, B., Vachon, C., & Tamimi, R. M. (2011). Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. Journal of the National Cancer Institute, 103(15), 1179–1189. doi:10.1093/jnci/djr225.
Hugh, J., Hanson, J., Cheang, M. C. U., Nielsen, T. O., Perou, C. M., Dumontet, C., … Vogel, C. (2009). Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 27(8), 1168–76. doi: 10.1200/JCO.2008.18.1024
Chang, R.-F., Chen, H.-H., Chang, Y.-C., Huang, C.-S., Chen, J.-H., & Lo, C.-M. (2016). Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI. Magnetic Resonance Imaging, 34(6), 809–819. doi:10.1016/j.mri.2016.03.001.
Park, S. Y., Kim, H. M., & Koo, J. S. (2015). Differential expression of cancer-associated fibroblast-related proteins according to molecular subtype and stromal histology in breast cancer. Breast Cancer Research and Treatment, 149(3), 727–741. doi:10.1007/s10549-015-3291-9.
Afik, R., Zigmond, E., Vugman, M., Klepfish, M., Shimshoni, E., Pasmanik-Chor, M., … Varol, C. (2016). Tumor macrophages are pivotal constructors of tumor collagenous matrix. Journal of Experimental Medicine.
Tchou, J., Kossenkov, A. V, Chang, L., Satija, C., Herlyn, M., Showe, L. C., … Gelmon, K. (2012). Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles. BMC Medical Genomics, 5(1), 39. doi: 10.1186/1755-8794-5-39
Galbraith, C. G., Yamada, K. M., & Sheetz, M. P. (2002). The relationship between force and focal complex development. Journal of Cell Biology, 159(4), 695–705. doi:10.1083/jcb.200204153.
White, D. E., Kurpios, N. A., Zuo, D., Hassell, J. A., Blaess, S., Mueller, U., & Muller, W. J. (2004). Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell, 6(2), 159–170. doi:10.1016/j.ccr.2004.06.025\rS1535610804002077 [pii].
Wozniak, M. a., Desai, R., Solski, P. a., Der, C. J., & Keely, P. J. (2003). ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix. The Journal of Cell Biology, 163(3), 583–595. doi:10.1083/jcb.200305010.
Provenzano, P. P., Inman, D. R., Eliceiri, K. W., & Keely, P. J. (2009). Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage. Oncogene, 28(49), 4326–4343. doi:10.1038/onc.2009.299.
Rubashkin, M. G., Cassereau, L., Bainer, R., DuFort, C. C., Yui, Y., Ou, G., … Weaver, V. M. (2014). Force engages vinculin and promotes tumor progression by enhancing PI3K activation of phosphatidylinositol (3,4,5)-triphosphate. Cancer Research, 74(17), 4597–4611. doi: 10.1158/0008-5472.CAN-13-3698
Mouw, J. K., Yui, Y., Damiano, L., Bainer, R. O., Lakins, J. N., Acerbi, I., … Weaver, V. M. (2014). Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression. Nature medicine, 20(4), 360–7. doi: 10.1038/nm.3497
Gehler, S., Ponik, S. M., Riching, K. M., & Keely, P. J. (2013). Bi-directional signaling: extracellular matrix and integrin regulation of breast tumor progression. Critical Reviews in Eukaryotic Gene Expression, 23(2), 139–157. doi:10.1615/CritRevEukarGeneExpr.2013006647.
Zhu, J., Xiong, G., Trinkle, C., & Xu, R. (2014). Integrated extracellular matrix signaling in mammary gland development and breast cancer progression. Histology and Histopathology, 29(9), 1083–1092. doi:10.1002/jcp.24872.The.
Franco, C., Hou, G., Ahmad, P. J., Fu, E. Y. K., Koh, L., Vogel, W. F., & Bendeck, M. P. (2008). Discoidin domain receptor 1 (Ddr1) deletion decreases atherosclerosis by accelerating matrix accumulation and reducing inflammation in low-density lipoprotein receptor-deficient mice. Circulation Research, 102(10), 1202–1211. doi:10.1161/CIRCRESAHA.107.170662.
Meyaard, L. (2008). The inhibitory collagen receptor LAIR-1 (CD305). Journal of Leukocyte Biology, 83(4), 799–803. doi:10.1189/jlb.0907609.
Houghton, A. M., Quintero, P. A., Perkins, D. L., Kobayashi, D. K., Kelley, D. G., Marconcini, L. A., … Shapiro, S. D. (2006). Elastin fragments drive disease progression in a murine model of emphysema. Journal of Clinical Investigation, 116(3), 753–759. doi: 10.1172/JCI25617
Krishnan, R., & Cleary, E. G. (1990). Elastin gene expression in elastotic human breast cancers and epithelial cell lines. Cancer Research, 50(7), 2164–2171.
García-Mendoza, M. G., Inman, D. R., Ponik, S. M., Jeffery, J. J., Sheerar, D. S., Van Doorn, R. R., & Keely, P. J. (2016). Neutrophils drive accelerated tumor progression in the collagen-dense mammary tumor microenvironment. Breast cancer research: BCR, 18(1), 49. doi:10.1186/s13058-016-0703-7.
Coussens, L. M., & Werb, Z. (2002). Inflammation and cancer. Nature, 420(6917), 860–867. doi:10.1038/nature01322.
Sieminski, A. L., Hebbel, R. P., & Gooch, K. J. (2004). The relative magnitudes of endothelial force generation and matrix stiffness modulate capillary morphogenesis in vitro. Experimental Cell Research, 297(2), 574–584. doi:10.1016/j.yexcr.2004.03.035.
Teo, N. B., Shoker, B. S., Jarvis, C., Martin, L., Sloane, J. P., & Holcombe, C. (2002). Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast. British Journal of Cancer, 86(6), 905–911. doi:10.1038/sj.bjc.6600053.
Mason, B. N., Starchenko, A., Williams, R. M., Bonassar, L. J., & Reinhart-King, C. A. (2013). Tuning three-dimensional collagen matrix stiffness independently of collagen concentration modulates endothelial cell behavior. Acta Biomaterialia, 9(1), 4635–4644. doi:10.1016/j.actbio.2012.08.007.
Kohn, J. C., Zhou, D. W., Bordeleau, F., Zhou, A. L., Mason, B. N., Mitchell, M. J., … Reinhart-King, C. A. (2015). Cooperative effects of matrix stiffness and fluid shear stress on endothelial cell behavior. Biophysical Journal, 108(3), 471–478. doi: 10.1016/j.bpj.2014.12.023
Kaplan, R. N., Rafii, S., & Lyden, D. (2006). Preparing the “soil”: the premetastatic niche. Cancer Research. doi:10.1158/0008-5472.CAN-06-2407.
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002). Dissemination and growth of cancer cells in metastatic sites. Nature reviews. Cancer, 2(8), 563–572. doi:10.1038/nrc865.
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009). Metastasis: from dissemination to organ-specific colonization. Nature reviews. Cancer, 9(4), 274–284. doi:10.1038/nrc2622.
Cox, T. R., Rumney, R. M., Schoof, E. M., Perryman, L., Hoye, A. M., Agrawal, A., … Erler, J. T. (2015). The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. Nature, 522(7554), 106–110. doi: 10.1038/nature14492
Miller, B. W., Morton, J. P., Pinese, M., Saturno, G., Jamieson, N. B., McGhee, E., … Sansom, O. J. (2015). Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy. EMBO Mol Med, 7, 1063–1076. doi: 10.15252/emmm
Erler, J. T., & Weaver, V. M. (2009). Three-dimensional context regulation of metastasis. Clinical and Experimental Metastasis, 26(1), 35–49. doi:10.1007/s10585-008-9209-8.
Giles, A. J., Reid, C. M., De Wayne Evans, J., Murgai, M., Vicioso, Y., Highfill, S. L., … Kaplan, R. N. (2016). Activation of hematopoietic stem/progenitor cells promotes immunosuppression within the pre-metastatic niche. Cancer Research, 76(6), 1335–1347. doi: 10.1158/0008-5472.CAN-15-0204
Gao, D., Joshi, N., Choi, H., Ryu, S., Hahn, M., Catena, R., … Mittal, V. (2012). Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition. Cancer Research, 72(6), 1384–1394. doi: 10.1158/0008-5472.CAN-11-2905
Kagan, H. M., & Li, W. (2003). Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. Journal of Cellular Biochemistry, 88(4), 660–672. doi:10.1002/jcb.10413.
Pfeiffer, B. J., Franklin, C. L., Hsieh, F. H., Bank, R. A., & Phillips, C. L. (2005). Alpha 2(I) collagen deficient oim mice have altered biomechanical integrity, collagen content, and collagen crosslinking of their thoracic aorta. Matrix Biology, 24(7), 451–458. doi:10.1016/j.matbio.2005.07.001.
Erler, J. T., Bennewith, K. L., Cox, T. R., Lang, G., Bird, D., Koong, A., … Giaccia, A. J. (2009). Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell, 15(1), 35–44. doi: 10.1016/j.ccr.2008.11.012
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Anna, H., Vincent, L., Costa, C., … Lyden, D. (2005). VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature, 438(7069), 820–827. doi: 10.1038/nature04186.VEGFR1-positive
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., … Giaccia, A. J. (2006). Lysyl oxidase is essential for hypoxia-induced metastasis. Nature, 440(7088), 1222–6. doi: 10.1038/nature04695
Wong, C. C.-L., Gilkes, D. M., Zhang, H., Chen, J., Wei, H., Chaturvedi, P., … Semenza, G. L. (2011). Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation. Proceedings of the National Academy of Sciences of the United States of America, 108(39), 16369–74. doi: 10.1073/pnas.1113483108
Fogelgren, B., Polgár, N., Szauter, K. M., Újfaludi, Z., Laczkó, R., Fong, K. S. K., & Csiszar, K. (2005). Cellular fibronectin binds to lysyl oxidase with high affinity and is critical for its proteolytic activation. Journal of Biological Chemistry, 280(26), 24690–24697. doi:10.1074/jbc.M412979200.
Høye, A. M., & Erler, J. T. (2016). Structural ECM components in the pre-metastatic and metastatic niche. American Journal of Physiology. Cell Physiology, 1(73) ajpcell.00326.2015. doi:10.1152/ajpcell.00326.2015.
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., … Lyden, D. (2015). Tumour exosome integrins determine organotropic metastasis. Nature, 527(7578), 329–35. doi: 10.1038/nature15756
Hsemann, Y., Geigl, J. B., Schubert, F., Musiani, P., Meyer, M., Burghart, E., … Klein, C. A. (2008). Systemic spread is an early step in breast cancer. Cancer Cell, 13(1), 58–68. doi: 10.1016/j.ccr.2007.12.003
Kennecke, H., Yerushalmi, R., Woods, R., Cheang, M. C. U., Voduc, D., Speers, C. H., … Gelmon, K. (2010). Metastatic behavior of breast cancer subtypes. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 28(20), 3271–7. doi: 10.1200/JCO.2009.25.9820
Rizwan, A., Bulte, C., Kalaichelvan, A., Cheng, M., Krishnamachary, B., Bhujwalla, Z. M., … Tyers, M. (2015). Metastatic breast cancer cells in lymph nodes increase nodal collagen density. Scientific Reports, 5, 10002. doi: 10.1038/srep10002
Koyama, T., Hasebe, T., Tsuda, H., Hirohashi, S., Sasaki, S., Fukutomi, T., … Mukai, K. (1999). Histological factors associated with initial bone metastasis of invasive ductal carcinoma of the breast. Japanese Journal of Cancer Research, 90(3), 294–300. doi: 10.1111/j.1349-7006.1999.tb00747.x
Lawson, D. A., Bhakta, N. R., Kessenbrock, K., Prummel, K. D., Yu, Y., Takai, K., … Werb, Z. (2015). Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells. Nature, 526(7571), 131–135. doi: 10.1038/nature15260
Oskarsson, T., Acharyya, S., Zhang, X. H.-F., Vanharanta, S., Tavazoie, S. F., Morris, P. G., … Massagué, J. (2011). Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nature medicine, 17(7), 867–74. doi: 10.1038/nm.2379
O’Connell, J. T., Sugimoto, H., Cooke, V. G., MacDonald, B. A., Mehta, A. I., LeBleu, V. S., … Kalluri, R. (2011). VEGF-A and tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization. Proceedings of the National Academy of Sciences of the United States of America, 108(38), 16002–7. doi: 10.1073/pnas.1109493108
Malanchi, I., Santamaria-Martínez, A., Susanto, E., Peng, H., Lehr, H.-A., Delaloye, J.-F., & Huelsken, J. (2011). Interactions between cancer stem cells and their niche govern metastatic colonization. Nature, 481(7379), 85–89. doi:10.1038/nature10694.
Aguirre-Ghiso, J. A., Liu, D., Mignatti, A., Kovalski, K., & Ossowski, L. (2001). Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Molecular Biology of the Cell, 12(4), 863–879.
Barkan, D., Green, J. E., & Chambers, A. F. (2010). Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth. European Journal of Cancer, 46(7), 1181–1188. doi:10.1016/j.ejca.2010.02.027.
Hayashi, M., Yamamoto, Y., Ibusuki, M., Fujiwara, S., Yamamoto, S., Tomita, S., … Iwase, H. (2012). Evaluation of tumor stiffness by elastography is predictive for pathologic complete response to neoadjuvant chemotherapy in patients with breast cancer. Annals of Surgical Oncology, 19(9), 3042–3049. doi: 10.1245/s10434-012-2343-1
Giussani, M., Merlino, G., Cappelletti, V., Tagliabue, E., & Daidone, M. G. (2015). Tumor-extracellular matrix interactions: identification of tools associated with breast cancer progression. Seminars in Cancer Biology. doi:10.1016/j.semcancer.2015.09.012.
Magzoub, M., Jin, S., & Verkman, a. S. (2008). Enhanced macromolecule diffusion deep in tumors after enzymatic digestion of extracellular matrix collagen and its associated proteoglycan decorin. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology, 22(1), 276–284. doi:10.1096/fj.07-9150com.
Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J., & Jain, R. K. (2000). Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Research, 60(9), 2497–2503. doi:10.1126/science.271.5252.1079.
Erikson, A., Andersen, H. N., Naess, S. N., Sikorski, P., & Davies, C. D. L. (2008). Physical and chemical modifications of collagen gels: impact on diffusion. Biopolymers, 89(2), 135–143. doi:10.1002/bip.20874.
Farmer, P., Bonnefoi, H., Anderle, P., Cameron, D., Wirapati, P., Becette, V., … Delorenzi, M. (2009). A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nature medicine, 15(1), 68–74. doi: 10.1038/nm0209-220a
Misra, S., Obeid, L. M., Hannun, Y. A., Minamisawa, S., Berger, F. G., Markwald, R. R., … Ghatak, S. (2008). Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells. Journal of Biological Chemistry, 283(21), 14335–14344. doi: 10.1074/jbc.M703811200
Jansen, M. P. H. M., Foekens, J. a, van Staveren, I. L., Dirkzwager-Kiel, M. M., Ritstier, K., Look, M. P., … Berns, E. M. J. J. (2005). Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 23(4), 732–40. doi: 10.1200/JCO.2005.05.145
Thurber, G. M., Schmidt, M. M., & Wittrup, K. D. (2008). Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance. Advanced Drug Delivery Reviews. doi:10.1016/j.addr.2008.04.012.
Holle, A. W., Young, J. L., & Spatz, J. P. (2016). In vitro cancer cell-ECM interactions inform in vivo cancer treatment. Advanced Drug Delivery Reviews. doi:10.1016/j.addr.2015.10.007.
Chrenek, M. a., Wong, P., & Weaver, V. M. (2001). Tumour-stromal interactions. Integrins and cell adhesions as modulators of mammary cell survival and transformation. Breast cancer research: BCR, 3(4), 224–229. doi:10.1186/bcr300.
Sloan, E. K., Pouliot, N., Stanley, K. L., Chia, J., Moseley, J. M., Hards, D. K., & Anderson, R. L. (2006). Tumor-specific expression of αvβ3 integrin promotes spontaneous metastasis of breast cancer to bone. Breast Cancer Research, 8(2), R20. doi:10.1186/bcr1398.
Seguin, L., Kato, S., Franovic, A., Camargo, M. F., Lesperance, J., Elliott, K. C., … Cheresh, D. A. (2014). An integrin β3-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition. Nature cell biology, 16(5), 457–68. doi: 10.1038/ncb2953
Barkan, D., & Chambers, A. F. (2011). B1-integrin: a potential therapeutic target in the battle against cancer recurrence. Clinical Cancer Research. doi:10.1158/1078-0432.CCR-11-0642.
Das, S., Ongusaha, P. P., Yang, Y. S., Park, J.-M., Aaronson, S. a., & Lee, S. W. (2006). Discoidin domain receptor 1 receptor tyrosine kinase induces cyclooxygenase-2 and promotes chemoresistance through nuclear factor-kappaB pathway activation. Cancer Research, 66, 8123–8130. doi:10.1158/0008-5472.CAN-06-1215.
Rammal, H., Saby, C., Magnien, K., Van-Gulick, L., Garnotel, R., Buache, E., … Morjani, H. (2016). Discoidin domain receptors: potential actors and targets in cancer. Frontiers in Pharmacology. doi: 10.3389/fphar.2016.00055
Bertout, J. A., Patel, S. A., & Simon, M. C. (2008). The impact of O2 availability on human cancer. Nature reviews. Cancer, 8(12), 967–975. doi:10.1038/nrc2540.
Pang, M.-F., Siedlik, M. J., Han, S., Stallings-Mann, M., Radisky, D. C., & Nelson, C. M. (2016). Tissue stiffness and hypoxia modulate the integrin-linked kinase ILK to control breast cancer stem-like cells. Cancer research. doi:10.1158/0008-5472.CAN-16-0579.
Al-Ejeh, F., Smart, C. E., Morrison, B. J., Chenevix-Trench, G., López, J. A., Lakhani, S. R., … Khanna, K. K. (2011). Breast cancer stem cells: treatment resistance and therapeutic opportunities. Carcinogenesis. doi: 10.1093/carcin/bgr028
Naumov, G. N., Townson, J. L., MacDonald, I. C., Wilson, S. M., Bramwell, V. H. C., Groom, A. C., & Chambers, A. F. (2003). Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Research and Treatment, 82(3), 199–206. doi:10.1023/B:BREA.0000004377.12288.3c.
Barkan, D., Kleinman, H., Simmons, J. L., Asmussen, H., Kamaraju, A. K., Hoenorhoff, M. J., … Green, J. E. (2008). Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Research, 68(15), 6241–6250. doi: 10.1158/0008-5472.CAN-07-6849
Schrader, J., Gordon-Walker, T. T., Aucott, R. L., van Deemter, M., Quaas, A., Walsh, S., … Iredale, J. P. (2011). Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells. Hepatology, 53(4), 1192–1205. doi: 10.1002/hep.24108
Tilghman, R. W., Blais, E. M., Cowan, C. R., Sherman, N. E., Grigera, P. R., Jeffery, E. D., … Parsons, J. T. (2012). Matrix rigidity regulates cancer cell growth by modulating cellular metabolism and protein synthesis. PLoS ONE, 7(5). doi: 10.1371/journal.pone.0037231
Pupa, S. M., Giuffré, S., Castiglioni, F., Bertola, L., Cantú, M., Bongarzone, I., … Tagliabue, E. (2007). Regulation of breast cancer response to chemotherapy by fibulin-1. Cancer Research, 67(9), 4271–4277. doi: 10.1158/0008-5472.CAN-06-4162
Peiris-Pagès, M., Sotgia, F., & Lisanti, M. P. (2015). Chemotherapy induces the cancer-associated fibroblast phenotype, activating paracrine Hedgehog-GLI signalling in breast cancer cells. Oncotarget, 6(13), 10728–10745. doi:10.18632/oncotarget.3828.
Kalluri, R., & Zeisberg, M. (2006). Fibroblasts in cancer. Nature reviews. Cancer, 6(5), 392–401. doi:10.1038/nrc1877.
Shen, C. J., Sharma, A., Vuong, D.-V., Erler, J. T., Pruschy, M., & Broggini-Tenzer, A. (2014). Ionizing radiation induces tumor cell lysyl oxidase secretion. BMC Cancer, 14(1), 532. doi:10.1186/1471-2407-14-532.
Liu, J., Liao, S., Diop-Frimpong, B., Chen, W., Goel, S., Naxerova, K., … Xu, L. (2012). TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma. Proceedings of the National Academy of Sciences of the United States of America, 109(41), 16618–23. doi: 10.1073/pnas.1117610109
Bondareva, A., Downey, C. M., Ayres, F., Liu, W., Boyd, S. K., Hallgrimsson, B., & Jirik, F. R. (2009). The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells. PloS One, 4(5), e5620. doi:10.1371/journal.pone.0005620.
Beckenlehner, K., Bannke, S., Spruss, T., Bernhardt, G., Schönenberg, H., & Schiess, W. (1992). Hyaluronidase enhances the activity of adriamycin in breast cancer models in vitro and in vivo. Journal of Cancer Research and Clinical Oncology, 118(8), 591–596.
Shuster, S., Frost, G. I., Csoka, A. B., Formby, B., & Stern, R. (2002). Hyaluronidase reduces human breast cancer xenografts in SCID mice. International Journal of Cancer, 102(2), 192–197. doi:10.1002/ijc.10668.
Pickup, M. W., Laklai, H., Acerbi, I., Owens, P., Gorska, A. E., Chytil, A., … Moses, H. L. (2013). Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-β-deficient mouse mammary carcinomas. Cancer Research, 73(17), 5336–5346. doi: 10.1158/0008-5472.CAN-13-0012
Barry-Hamilton, V., Spangler, R., Marshall, D., McCauley, S., Rodriguez, H. M., Oyasu, M., … Smith, V. (2010). Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment. Nature medicine, 16(9), 1009–17. doi: 10.1038/nm.2208
Chan, N., Willis, A., Kornhauser, N., Ward, M. M., Lee, S. B., Nackos, E., … Vahdat, L. (2016). Influencing the tumor microenvironment: phase 2 study of copper depletion with tetrathiomolybdate in high risk breast cancer and preclinical models of lung metastases. Clinical Cancer Research.
Golubovskaya, V. M., & Cance, W. G. (2007). Focal adhesion kinase and p53 signaling in cancer cells. International Review of Cytology, 263(7), 103–153. doi:10.1016/S0074-7696(07)63003-4.
Mitra, S. K., & Schlaepfer, D. D. (2006). Integrin-regulated FAK-Src signaling in normal and cancer cells. Current Opinion in Cell Biology, 18(5), 516–523. doi:10.1016/j.ceb.2006.08.011.
Tanjoni, I., Walsh, C., Uryu, S., Tomar, A., Nam, J.-O., Mielgo, A., … Schlaepfer, D. D. (2010). PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments. Cancer biology & therapy, 9(10), 764–77.
Walsh, C., Tanjoni, I., Uryu, S., Tomar, A., Nam, J.-O., Luo, H., … Schlaepfer, D. D. (2010). Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models. Cancer biology & therapy, 9(10), 778–90.
Acknowledgements
The authors apologize to all colleagues whose work could not be cited due to space limitations. The authors would like to thank Dr. Janna Mouw for her insightful review of the manuscript. This work was supported by NIH grant RO1CA192914, USMRAA (DOD) grant BC122990, U54 grant CA210184, and UO1 grant CA202241-01.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaushik, S., Pickup, M.W. & Weaver, V.M. From transformation to metastasis: deconstructing the extracellular matrix in breast cancer. Cancer Metastasis Rev 35, 655–667 (2016). https://doi.org/10.1007/s10555-016-9650-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10555-016-9650-0